Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 10;25(10):5209.
doi: 10.3390/ijms25105209.

Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei

Affiliations

Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei

Inês Costa et al. Int J Mol Sci. .

Abstract

Mycoses are one of the major causes of morbidity/mortality among immunocompromised individuals. Considering the importance of these infections, the World Health Organization (WHO) defined a priority list of fungi for health in 2022 that include Candida albicans as belonging to the critical priority group and Pichia kudriavzevii (Candida krusei) to the medium priority group. The existence of few available antifungal drugs, their high toxicity, the acquired fungal resistance, and the appearance of new species with a broader spectrum of resistance, points out the need for searching for new antifungals, preferably with new and multiple mechanisms of action. The cyclam salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 was previously tested against several fungi and revealed an interesting activity, with minimal inhibitory concentration (MIC) values of 8 µg/mL for C. krusei and of 128 µg/mL for C. albicans. The main objective of the present work was to deeply understand the mechanisms involved in its antifungal activity. The effects of the cyclam salt on yeast metabolic viability (resazurin reduction assay), yeast mitochondrial function (JC-1 probe), production of reactive oxygen species (DCFH-DA probe) and on intracellular ATP levels (luciferin/luciferase assay) were evaluated. H4[H2(4-CF3PhCH2)2Cyclam]Cl4 induced a significant decrease in the metabolic activity of both C. albicans and C. krusei, an increase in Reactive Oxygen Species (ROS) production, and an impaired mitochondrial function. The latter was observed by the depolarization of the mitochondrial membrane and decrease in ATP intracellular levels, mechanisms that seems to be involved in the antifungal activity of H4[H2(4-CF3PhCH2)2Cyclam]Cl4. The interference of the cyclam salt with human cells revealed a CC50 value against HEK-293 embryonic kidney cells of 1.1 μg/mL and a HC10 value against human red blood cells of 0.8 μg/mL.

Keywords: cyclam salt; mechanism of action; metabolic viability; mitochondrial function; yeasts.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Chemical structure of H4[H2(4-CF3PhCH2)2Cyclam]Cl4 (1).
Figure 2
Figure 2
Effects of different concentrations of compound 1 on the metabolic activity of (a) Candida krusei ATCC 6258 and (b) Candida albicans ATCC 10231. Results are presented as Mean + SD from 4 or 5 independent experiments, performed in duplicate. * p < 0.05; ** p ˂ 0.01; *** p < 0.001. MIC, minimal inhibitory concentration.
Figure 3
Figure 3
Effects of different concentrations of compound 1 on the mitochondrial membrane potential (ΔΨm) of (a) Candida krusei ATCC 6258 and (b) Candida albicans ATCC 10231, evaluated using the JC-1 dye. Results are presented as Mean + SD from 4 or 5 independent experiments, performed in duplicate. * p < 0.05; **** p ˂ 0.0001. MIC, minimal inhibitory concentration.
Figure 4
Figure 4
Effects of compound 1 on reactive oxygen species (ROS) production in (a) Candida krusei ATCC 6258 and (b) Candida albicans ATCC 10231 after 2 and 6 h of treatment. Results are presented as Mean + SD from 4 or 5 independent experiments, performed in duplicate [* p ˂ 0.05, ** p ˂ 0.01, *** p ˂ 0.001 and **** p ˂ 0.0001, for comparisons between concentrations at each timepoint; # p ˂ 0.05 and #### p ˂ 0.0001, for comparisons between timepoints at each concentration]. MIC, minimal inhibitory concentration.
Figure 5
Figure 5
Effects of compound 1 on ATP intracellular levels in (a) Candida krusei ATCC 6258 and (b) Candida albicans ATCC 10231 cells. Results are presented as Mean + SD from 4 or 5 independent experiments, performed in duplicate. *** p < 0.001. MIC, minimal inhibitory concentration.

References

    1. Gold J.A.W., Ahmad F.B., Cisewski J.A., Rossen L.M., Montero A.J., Benedict K., Jackson B.R., Toda M. Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic-National Vital Statistics System, United States, January 2020–December 2021. Clin. Infect. Dis. 2023;76:e255–e262. doi: 10.1093/cid/ciac489. - DOI - PMC - PubMed
    1. Denning D.W. Global incidence and mortality of severe fungal disease. Lancet Infect. Dis. 2024 doi: 10.1016/s1473-3099(23)00692-8. - DOI - PubMed
    1. World Health Organization (WHO) WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. WHO; Geneva, Switzerland: 2022.
    1. World Health Organization (WHO) United Nations Environment Programme and World Organisation for Animal Health: A Guide to Implementing the One Health Joint Plan of Action at National Level. WHO; Geneva, Switzerland: 2023.
    1. Fisher M.C., Alastruey-Izquierdo A., Berman J., Bicanic T., Bignell E.M., Bowyer P., Bromley M., Brüggemann R., Garber G., Cornely O.A., et al. Tackling the emerging threat of antifungal resistance to human health. Nat. Rev. Microbiol. 2022;20:557–571. doi: 10.1038/s41579-022-00720-1. - DOI - PMC - PubMed

MeSH terms

Supplementary concepts

LinkOut - more resources